Technologies

The Pharmorage technologies are focused on modulating inflammation at its source, with a focus on improving mRNA vaccines and treating autoimmune diseases.

Toll-like receptors (TLR7 or TLR8) are targeted using proprietary ultra-short 3-base oligonucleotides to either up- or down-regulate inflammatory responses.

mRNA vaccines and therapeutics

Autoimmune disease